Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors

Details Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors

C - Chemistry, Metallurgy

07

D

C07D 403/04 (2006.01) A61K 31/496 (2006.01) A61K 31/506 (2006.01) A61K 31/5377 (2006.01) A61P 35/00 (2006.01) C07D 401/04 (2006.01) C07D 401/14 (2006.01) C07D 403/14 (2006.01) C07D 409/04 (2006.01) C07D 413/14 (2006.01)

Patent

CA 2636824

There are provided compounds of the formula (I), wherein R, V1, V2 and Ring A are described herein. The compounds exhibit anticancer activity.

L'invention concerne des composés de formule (I), dans laquelle R, V1, V2 et le cycle A sont tels que définis dans la description. Ces composés présentent une activité anticancéreuse.

Affiliated with

Also associated with

Rating

Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1750925